Company profile TSVT
After 39 days of this quarter the interest is at 133.0. Based on that we can calculate that during remaining 52 days it will total up to 310.0. 2seventy bio expected interest is significantly higher compared to previous quarter (+55.8%) and same quarter last year (+46.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 16 | 0 -100.0% QoQ | 36 inf% QoQ | 9 -75.0% QoQ |
| 2020 | 23 43.8% YoY 155.6% QoQ | 17 inf% YoY -26.1% QoQ | 14 -61.1% YoY -17.6% QoQ | 30 233.3% YoY 114.3% QoQ |
| 2021 | 21 -8.7% YoY -30.0% QoQ | 46 170.6% YoY 119.0% QoQ | 73 421.4% YoY 58.7% QoQ | 254 746.7% YoY 247.9% QoQ |
| 2022 | 508 2319.0% YoY 100.0% QoQ | 223 384.8% YoY -56.1% QoQ | 118 61.6% YoY -47.1% QoQ | 221 -13.0% YoY 87.3% QoQ |
| 2023 | 211 -58.5% YoY -4.5% QoQ | 234 4.9% YoY 10.9% QoQ | 212 79.7% YoY -9.4% QoQ | 199 -10.0% YoY -6.1% QoQ |
| 2024 | 133 -37.0% YoY -33.2% QoQ | - | - | - |
The average 5 years interest of 2seventy bio was 9.95 per week. The last year interest of 2seventy bio compared to the last 5 years has changed by 70.65%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 1351.28%.
After 39 days of this quarter the interest is at 130.0. Based on that we can calculate that during remaining 52 days it will total up to 303.0. gene therapy company expected interest is significantly higher compared to previous quarter (+106.1%) and same quarter last year (+148.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 47 | 158 236.2% QoQ | 87 -44.9% QoQ | 114 31.0% QoQ |
| 2020 | 91 93.6% YoY -20.2% QoQ | 142 -10.1% YoY 56.0% QoQ | 169 94.3% YoY 19.0% QoQ | 119 4.4% YoY -29.6% QoQ |
| 2021 | 284 212.1% YoY 138.7% QoQ | 112 -21.1% YoY -60.6% QoQ | 140 -17.2% YoY 25.0% QoQ | 132 10.9% YoY -5.7% QoQ |
| 2022 | 206 -27.5% YoY 56.1% QoQ | 115 2.7% YoY -44.2% QoQ | 126 -10.0% YoY 9.6% QoQ | 116 -12.1% YoY -7.9% QoQ |
| 2023 | 122 -40.8% YoY 5.2% QoQ | 162 40.9% YoY 32.8% QoQ | 149 18.3% YoY -8.0% QoQ | 147 26.7% YoY -1.3% QoQ |
| 2024 | 130 6.6% YoY -11.6% QoQ | - | - | - |
The average 5 years interest of gene therapy company was 10.99 per week. The last year interest of gene therapy company compared to the last 5 years has changed by 17.2%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 58.62%.
There is not enough data for chimeric antigen receptor-T cell to provide analysis
There is not enough data for chimeric antigen receptor-T cell to provide correlation calculation
There is not enough data for chimeric antigen receptor-T cell to provide analysis
After 34 days of this quarter the interest is at 422.0. Based on that we can calculate that during remaining 58 days it will total up to 1142.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 544 |
| 2019 | 956 75.7% QoQ | 951 -0.5% QoQ | 914 -3.9% QoQ | 975 79.2% YoY 6.7% QoQ |
| 2020 | 990 3.6% YoY 1.5% QoQ | 814 -14.4% YoY -17.8% QoQ | 936 2.4% YoY 15.0% QoQ | 929 -4.7% YoY -0.7% QoQ |
| 2021 | 869 -12.2% YoY -6.5% QoQ | 915 12.4% YoY 5.3% QoQ | 951 1.6% YoY 3.9% QoQ | 917 -1.3% YoY -3.6% QoQ |
| 2022 | 886 2.0% YoY -3.4% QoQ | 897 -2.0% YoY 1.2% QoQ | 859 -9.7% YoY -4.2% QoQ | 860 -6.2% YoY 0.1% QoQ |
| 2023 | 947 6.9% YoY 10.1% QoQ | 946 5.5% YoY -0.1% QoQ | 900 4.8% YoY -4.9% QoQ | 422 -50.9% YoY -53.1% QoQ |
The average 5 years interest of cancer treatment was 70.41 per week. The last year interest of cancer treatment compared to the last 5 years has changed by 0.24%. The interest for cancer treatment is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by -1.58%.
After 39 days of this quarter the interest is at 111.0. Based on that we can calculate that during remaining 52 days it will total up to 259.0. idecabtagene vicleucel expected interest is significantly higher compared to previous quarter (+793.1%) and same quarter last year (+60.9%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 70 | 159 127.1% QoQ | 50 -68.6% QoQ | 42 -16.0% QoQ |
| 2020 | 50 -28.6% YoY 19.0% QoQ | 128 -19.5% YoY 156.0% QoQ | 180 260.0% YoY 40.6% QoQ | 142 238.1% YoY -21.1% QoQ |
| 2021 | 76 52.0% YoY -46.5% QoQ | 256 100.0% YoY 236.8% QoQ | 216 20.0% YoY -15.6% QoQ | 185 30.3% YoY -14.4% QoQ |
| 2022 | 66 -13.2% YoY -64.3% QoQ | 181 -29.3% YoY 174.2% QoQ | 136 -37.0% YoY -24.9% QoQ | 116 -37.3% YoY -14.7% QoQ |
| 2023 | 161 143.9% YoY 38.8% QoQ | 159 -12.2% YoY -1.2% QoQ | 181 33.1% YoY 13.8% QoQ | 29 -75.0% YoY -84.0% QoQ |
| 2024 | 111 -31.1% YoY 282.8% QoQ | - | - | - |
The average 5 years interest of idecabtagene vicleucel was 10.32 per week. The last year interest of idecabtagene vicleucel compared to the last 5 years has changed by 8.04%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 68.94%.
There is not enough data for ide-cel or Abecma and bb21217 to provide analysis
There is not enough data for ide-cel or Abecma and bb21217 to provide correlation calculation
There is not enough data for ide-cel or Abecma and bb21217 to provide analysis
There is not enough data for Bristol-Myers Squibb collaboration to provide analysis
There is not enough data for Bristol-Myers Squibb collaboration to provide correlation calculation
There is not enough data for Bristol-Myers Squibb collaboration to provide analysis
After 39 days of this quarter the interest is at 349.0. Based on that we can calculate that during remaining 52 days it will total up to 814.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 248 | 362 46.0% QoQ | 304 -16.0% QoQ | 386 27.0% QoQ |
| 2020 | 356 43.5% YoY -7.8% QoQ | 427 18.0% YoY 19.9% QoQ | 348 14.5% YoY -18.5% QoQ | 419 8.5% YoY 20.4% QoQ |
| 2021 | 431 21.1% YoY 2.9% QoQ | 469 9.8% YoY 8.8% QoQ | 395 13.5% YoY -15.8% QoQ | 472 12.6% YoY 19.5% QoQ |
| 2022 | 758 75.9% YoY 60.6% QoQ | 700 49.3% YoY -7.7% QoQ | 623 57.7% YoY -11.0% QoQ | 710 50.4% YoY 14.0% QoQ |
| 2023 | 839 10.7% YoY 18.2% QoQ | 803 14.7% YoY -4.3% QoQ | 584 -6.3% YoY -27.3% QoQ | 821 15.6% YoY 40.6% QoQ |
| 2024 | 349 -58.4% YoY -57.5% QoQ | - | - | - |
The average 5 years interest of cell and gene therapy was 41.39 per week. The last year interest of cell and gene therapy compared to the last 5 years has changed by 41.94%. The interest for cell and gene therapy is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 113.48%.
After 39 days of this quarter the interest is at 225.0. Based on that we can calculate that during remaining 52 days it will total up to 525.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 369 | 628 70.2% QoQ | 630 0.3% QoQ | 591 -6.2% QoQ |
| 2020 | 668 81.0% YoY 13.0% QoQ | 522 -16.9% YoY -21.9% QoQ | 608 -3.5% YoY 16.5% QoQ | 526 -11.0% YoY -13.5% QoQ |
| 2021 | 476 -28.7% YoY -9.5% QoQ | 627 20.1% YoY 31.7% QoQ | 593 -2.5% YoY -5.4% QoQ | 604 14.8% YoY 1.9% QoQ |
| 2022 | 652 37.0% YoY 7.9% QoQ | 642 2.4% YoY -1.5% QoQ | 595 0.3% YoY -7.3% QoQ | 579 -4.1% YoY -2.7% QoQ |
| 2023 | 709 8.7% YoY 22.5% QoQ | 677 5.5% YoY -4.5% QoQ | 732 23.0% YoY 8.1% QoQ | 722 24.7% YoY -1.4% QoQ |
| 2024 | 225 -68.3% YoY -68.8% QoQ | - | - | - |
The average 5 years interest of multiple myeloma treatment was 47.41 per week. The last year interest of multiple myeloma treatment compared to the last 5 years has changed by 12.04%. The interest for multiple myeloma treatment is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 10.14%.